11 participants
A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-07-30
- Start Date:
- 2009-03-31
- Completion:
- 2011-03-31
Conditions
- Non-Small Cell Lung Cancer
Interventions
- DRUG